Infinitopes Appoints Immuno-Oncology Pioneer Jo Brewer as Chief Scientific Officer (CSO) to Advance Therapeutic Pipeline From Clinical to Commercialisation
· for further information please contact:
AI Briefing
- Infinitopes appoints Jo Brewer as CSO to advance therapeutic pipeline, builds on prior role as non-executive director, brings industry leadership to executive team.
Advertisement